Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...
With symptoms that often mimic other respiratory conditions, ILD is frequently misdiagnosed or unrecognized. However, in the ...
Lung ultrasound outperformed symptom-based screening questionnaires for ILD-RA detection, according to a recent study ...
University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...
An ex-RAF nurse has said that the detection of her rare disease was all thanks to an accidental collision with her family's ...
The following is a summary of “Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung ...
SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology ...
Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...
Apollo Hospitals successfully hosted ASPIRE 2025 (Apollo Symposium on Pulmonary Interventions and Respiratory Excellence) in Hyderabad.
Patients with LORA and CLD at baseline had lower rates of treatment response and a higher risk for SAEs over 5 years, compared against those without CLD.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results